Nantahala Capital Management’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-23,830
| Closed | -$397K | – | 126 |
|
|
2022
Q1 | $397K | Sell |
23,830
-4,088
| -15% | -$68.1K | 0.02% | 94 |
|
|
2021
Q4 | $1.82M | Sell |
27,918
-1,013
| -4% | -$65.9K | 0.06% | 85 |
|
|
2021
Q3 | $1.98M | Sell |
28,931
-1,371
| -5% | -$93.9K | 0.06% | 84 |
|
|
2021
Q2 | $2.11M | Hold |
30,302
| – | – | 0.06% | 84 |
|
|
2021
Q1 | $1.99M | Hold |
30,302
| – | – | 0.06% | 82 |
|
|
2020
Q4 | $1.74M | Buy |
30,302
+1,891
| +7% | +$109K | 0.05% | 91 |
|
|
2020
Q3 | $1.69M | Buy |
28,411
+299
| +1% | +$17.8K | 0.05% | 87 |
|
|
2020
Q2 | $3.64M | Hold |
28,112
| – | – | 0.11% | 73 |
|
|
2020
Q1 | $1.65M | Buy |
28,112
+334
| +1% | +$19.5K | 0.06% | 76 |
|
|
2019
Q4 | $3.51M | Hold |
27,778
| – | – | 0.11% | 59 |
|
|
2019
Q3 | $3.32M | Buy |
+27,778
| New | +$3.32M | 0.12% | 64 |
|